• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer

Drug Delivery Business

  • Clinical Trials
  • Research & Development
  • Drug-Device Combinations
  • FDA
  • Pharmaceuticals
  • Policy

Wound Care

How slugs are creating better medical adhesives

August 4, 2017 By Danielle Kirsh

Slug mucus is the inspiration behind a new adhesive to close surgical wounds and reduce the use of surgical staples, according to new research out of Harvard. Some of the current adhesives on the market can be toxic and stick together tissues weakly. Some can’t be used in wet environments altogether, which can pose a […]

Filed Under: Research & Development, Surgical, Wound Care Tagged With: hemostat, medtech, surgical adhesive

This bacterial discovery could prevent biofilms

June 9, 2017 By Danielle Kirsh

Researchers at the University of Texas at Austin have discovered a potential new way to eliminate biofilms to reduce the number of hospital-borne infections. Biofilms are a group of microorganisms that stick to a surface. Over time, the cells in the biofilm can grow and cause chronic infections and can even become resistant to antibiotics. […]

Filed Under: Featured, Research & Development, Wound Care Tagged With: bacteria, biofilm, infections, University of Texas at Austin

Small Utah biotech regenerates skin, hair in pigs

June 8, 2017 By Sarah Faulkner

PolarityTe

Utah-based biotech PolarityTe Inc. (NSDQ:COOL) has successfully regenerated skin and triggered hair growth in pigs with burns and abrasions. The breakthrough is a win in regenerative medicine, especially for tissue engineers hoping to help burn victims recover their skin. The firm’s approach involves using a patient’s own healthy tissue to grow human skin as a […]

Filed Under: Featured, Preclinical Trials, Regenerative Medicine, Wound Care Tagged With: polarityte

Cytori launches next-gen Celution cell therapy tech

June 1, 2017 By Sarah Faulkner

Cytori Therapeutics

Cytori Therapeutics (NSDQ:CYTX) said today that the next-gen version of its Celution cell therapy device is available for pre-order and that the 1st shipments will start in the 3rd quarter of 2017. The San Diego-based company’s Celution system automates the extraction and concentration of autologous, clinical-grade adipose-derived regenerative cells. The next-gen Celution tech includes new […]

Filed Under: Drug-Device Combinations, Featured, Regenerative Medicine, Wall Street Beat, Wound Care Tagged With: Cytori Therapeutics

Medtech stories we missed this week: April 14, 2017

April 14, 2017 By Danielle Kirsh

From FDA approvals to business expansion plans, here are medtech stories we missed this week but thought were still worth mentioning. 1. BioTelemetry launches offer to acquire LifeWatch BioTelemetry and LifeWatch announced in an April 9 press release that the 2 companies have entered a transaction agreement that states BioTelemetry will launch a tender offer to acquire all […]

Filed Under: Clinical Trials, Food & Drug Administration (FDA), Optical/Ophthalmic, Research & Development, Wound Care Tagged With: Acelity, BioTelemetry, CollPlant, LifeWatch, medtech, Second Sight, Sight Science, Toshiba Medical

How the CellMist SkinGun heals: a Q&A with RenovaCare’s CEO

April 5, 2017 By Chris Newmarker

RenovaCare CellMist SkinGun

Heather Thompson, Senior Editor When Thomas Bold joined RenovaCare in 2013, he was already familiar with its potentially groundbreaking technology. Bold had served as StemCell Systems CEO in Berlin for many years. He was involved in the development of the CellMist and SkinGun – the platform technologies for RenovaCare Inc. The technologies represent a shift in thinking about wound care, […]

Filed Under: Drug-Device Combinations, Featured, Stem Cells, Wound Care Tagged With: medtech, RenovaCare, stem cells, wound care

Integra, Dr. Reddy’s ink deal for DuraGen in India

March 27, 2017 By Sarah Faulkner

Integra LifeSciences (NSDQ:IART) and Dr. Reddy’s Laboratories (NYSE:RDY) inked an exclusive distribution agreement for the DuraGen Plus and suturable DuraGen Dural Regeneration Matrices in India. According to the deal, Dr. Reddy’s will market and distribute the medical devices throughout India. The DuraGen Plus Dural Regeneration Matrix is indicated as a dural susbtitute for the repair of […]

Filed Under: Featured, Implants, Surgical, Wound Care Tagged With: Dr. Reddy's Laboratories, Integra LifeSciences

Organogenesis launches PuraPly antimicrobial clinical program

March 27, 2017 By Sarah Faulkner

Organogenesis acquires NuTech Medical

Organogenesis said today that it launched its PuraPly Antimicrobial clinical research program, which will evaluate patients treated with PuraPly AM for up to 12 weeks. The 1st studies have started enrolling patients, according to Organogenesis. The Canton, Mass.-based company’s PuraPly AM is a 510(k)-cleared device indicated for the management of acute and chronic wounds. The […]

Filed Under: Clinical Trials, Featured, Wall Street Beat, Wound Care Tagged With: Organogenesis Inc.

The stem cell ‘skin gun’ that’s aiming to disrupt wound care

March 23, 2017 By Sarah Faulkner

RenovaCare’s SkinGun uses a patient’s own stem cells to heal their wounds faster and more efficiently than a traditional skin graft. Pennsylvania state police officer Matthew Uram suffered severe second-degree burns to his face, right arm and leg after a friend’s bonfire got out of control. Uram was facing months of painful skin grafts, the […]

Filed Under: Featured, Stem Cells, Wound Care Tagged With: RenovaCare

Origin treats first patients in study of nitric oxide for diabetic foot ulcers

March 22, 2017 By Sarah Faulkner

Origin treats first patients in study of nitric oxide for diabetic foot ulcers

Origin said today that it treated the 1st patients in its dose-ranging Genesis Phase IIb-equivalent trial. The study is evaluating therapeutic quantities of plasma-generated nitric oxide as a treatment for chronic diabetic foot ulcers. The 27-week trial is slated to enroll up to 100 patients. Patients will be randomized into 1 of 4 dosing regimens, […]

Filed Under: Clinical Trials, Diabetes, Featured, Wall Street Beat, Wound Care Tagged With: Origin

  • « Go to Previous Page
  • Go to page 1
  • Go to page 2
  • Go to page 3
  • Go to page 4
  • Go to Next Page »

Primary Sidebar

MEDTECH 100 INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.
Need Drug Delivery Business News in a minute? We Deliver!
Drug Delivery Enewsletters get you caught up on all the mission critical news you need in med tech. Sign up today.

Signup for the newsletter

Footer

Drug Delivery Business News Logo

MassDevice Medical NETWORK

MassDevice
DeviceTalks
Medical Tubing & Extrusion
Medical Design & Outsourcing
MedTech 100 Index
Drug Discovery & Development
Pharmaceutical Processing World
Medical Design Souring
R&D World

DRUG DELIVERY BUSINESS NEWS

Subscribe to Drug Delivery’s E-Newsletter
Advertise with us
About
Contact us
Privacy
Listen to our Weekly Podcasts
Add us on FacebookFollow us on TwitterConnect with us on LinkedIn

Copyright © 2022 · WTWH Media LLC and its licensors. All rights reserved.
The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media.

Advertise | Privacy Policy | RSS